Corvus Pharmaceuticals CRVS
NASDAQ CRVS
$10.90 -0.03 (-0.27%)
At close: Oct 2, 2026 · 4:00 PM EDT

Corvus Pharmaceuticals (CRVS) Property, Plant & Equipment (Net) (2015 - 2026)

Updated

Corvus Pharmaceuticals' Property, Plant & Equipment (Net) came in at $830,000 for Q2 2026, up 233.3% from $249,000 a year earlier and up 194.3% from the prior quarter.

Analysis

Corvus Pharmaceuticals (CRVS) Property, Plant & Equipment (Net) (2015 - 2026) Analysis & Trends

At the end of FY2025, Corvus Pharmaceuticals' Property, Plant & Equipment (Net) was $220,000, up 45.7% from FY2024.

  • Property, Plant & Equipment (Net) carries a five-year compound annual growth rate of -24.7% (FY2020 to FY2025).
  • Going back by year, Property, Plant & Equipment (Net) was $151,000 in FY2024 (-36.0%), $236,000 in FY2023 (-33.1%), $353,000 in FY2022 (-21.7%) and $451,000 in FY2021 (-50.2%).
  • The Q2 2026 figure represents the highest quarterly Property, Plant & Equipment (Net) since Q4 2020.
  • Year-over-year, Property, Plant & Equipment (Net) has increased for five consecutive quarters, with growth averaging 39.4% over the last eight quarters.
  • The fastest year-over-year change in Property, Plant & Equipment (Net) over five years came in Q2 2026 (growth of 233.3%), and the weakest in Q1 2022 (a decline of 52.7%).
  • Business Quant data shows CRVS's Property, Plant & Equipment (Net) at $282,000 (Q1 2026), $220,000 (Q4 2025) and $221,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 29.29 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 23.58 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 5.80 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 25.74 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 10.69 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 13.62 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 8.55 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 5.83 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 19.03 Bn
10 Corvus Pharmaceuticals 916.92 Mn 405.36 Mn - 830,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 830,000.00
Mar 31, 2026 282,000.00
Dec 31, 2025 220,000.00
Sep 30, 2025 221,000.00
Jun 30, 2025 249,000.00
Mar 31, 2025 165,000.00
Dec 31, 2024 151,000.00
Sep 30, 2024 171,000.00
Jun 30, 2024 192,000.00
Mar 31, 2024 213,000.00
Dec 31, 2023 236,000.00
Sep 30, 2023 264,000.00
Jun 30, 2023 294,000.00
Mar 31, 2023 330,000.00
Dec 31, 2022 353,000.00
Sep 30, 2022 447,000.00
Jun 30, 2022 527,000.00
Mar 31, 2022 364,000.00
Dec 31, 2021 451,000.00
Sep 30, 2021 539,000.00
API Access

Corvus Pharmaceuticals Property, Plant & Equipment (Net) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=CRVS&period=max&api_key=YOUR_API_KEY